Stephen R. Walsh

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 38 papers. Top paper: “Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial”.

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial

Nature Medicine(2022)10.1038/s41591-022-01815-1

N/A

2.7DataRank · unranked

143 citations

Kathryn E. Stephenson, Kshitij Wagh, Sabrina C. Tan, Rebecca Zash, Stephen R. Walsh +32 more

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0

N/A

2.7DataRank · unranked

91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature Medicine(2021)10.1038/s41591-021-01509-0

N/A

2.3DataRank · unranked

104 citations

Boris Jülg, Chen Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle +35 more

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

The Lancet Infectious Diseases(2020)10.1016/s1473-3099(20)30085-2

N/A

2.1DataRank · unranked

58 citations

Chen Sabrina Tan, Stephen R. Walsh, Andrew J. Hale, Jessica L. Ansel, Diane G. Kanjilal +21 more

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

PLoS Medicine(2021)10.1371/journal.pmed.1003868

N/A

1.1DataRank · unranked

25 citations

Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia-Morales +11 more

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)

The Lancet HIV(2020)10.1016/s2352-3018(20)30001-1

N/A

0.934DataRank · unranked

25 citations

Frank Wegmann, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +27 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445

N/A

0.872DataRank · unranked

36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2021)10.1038/s41467-021-22446-z

N/A

0.852DataRank · unranked

292 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2021)10.1038/s41467-021-23559-1

N/A

0.802DataRank · unranked

11 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

Nature Communications(2024)10.1038/s41467-023-44090-5

N/A

0.617DataRank · unranked

60 citations

Naresh Doni Jayavelu, Shanshan Liu, Esther Melamed, Carly E. Milliren, Jingjing Qi +95 more

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

Journal of Clinical Investigation(2023)10.1172/jci163338

N/A

0.553DataRank · unranked

14 citations

Andrew Fioré-Gartland, Stephen R. Walsh, Karina Yusim, Nicole Frahm, Marnie Elizaga +25 more

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2024)10.1038/s41467-024-45360-6

N/A

0.479DataRank · unranked

9 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

PLoS Medicine(2024)10.1371/journal.pmed.1004329

N/A

0.438DataRank · unranked

16 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +29 more

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial

Journal of Clinical Investigation(2021)10.1172/jci150823

N/A

0.410DataRank · unranked

6 citations

Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E. McLaren +12 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Vaccine Induction of Heterologous HIV-1 Neutralizing Antibody B Cell Lineages in Humans

medRxiv(2023)10.1101/2023.03.09.23286943

N/A

0.376DataRank · unranked

7 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +38 more

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals

medRxiv(2024)10.1101/2024.03.15.24304305

N/A

0.375DataRank · unranked

7 citations

Wilton B. Williams, Stephen R. Walsh, Derek W. Cain, Matthew Clark, Ryan Tuck +38 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

medRxiv(2024)10.1101/2024.01.10.23299799

N/A

0.208DataRank · unranked

3 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +28 more

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2025)10.1016/j.cell.2025.10.023

N/A

0.165DataRank · unranked

2 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +43 more

Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort

Journal of Allergy and Clinical Immunology Global(2025)10.1016/j.jacig.2025.100515

N/A

0.165DataRank · unranked

2 citations

Jingjing Qi, Carly E. Milliren, Al Ozonoff, Shanshan Liu, Ofer Levy +87 more

Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.12.688003

N/A

0DataRank · unranked

0 citations

Jennifer Fields, Joshua A. Wiener, Marissa Lindman, Alejandro B. Balazs, Michael S. Seaman +6 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

A retrospective analysis of incident pregnancy in Phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

Research Square(2020)10.21203/rs.3.rs-23939/v1

N/A

0DataRank · unranked

0 citations

Chenchen Yu, Margaret Brewinski Isaacs, Mary Allen, Jessica Andriesen, Stephen R. Walsh +1 more

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

BMC Infectious Diseases(2021)10.1186/s12879-021-06431-x

N/A

0DataRank · unranked

2 citations

Chenchen Yu, Margaret Brewinski Isaacs, Mary Allen, Jessica Andriesen, Stephen R. Walsh +1 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants

PLOS Global Public Health(2023)10.1371/journal.pgph.0002037

N/A

0DataRank · unranked

7 citations

Xue Han, Shannon Grant, Esther Kwara, Bharathi Lakshminarayanan, Michael Stirewalt +9 more

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad349

N/A

0DataRank · unranked

7 citations

Trevor A. Crowell, Muneerah M Aleissa, Ana‐Mihaela Lupan, Sonya Davey, Jun Bai Park Chang +4 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2024)10.1016/j.cell.2024.04.033

N/A

0DataRank · unranked

50 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +43 more

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy

npj Vaccines(2024)10.1038/s41541-024-00876-2

N/A

0DataRank · unranked

7 citations

Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, Chen Sabrina Tan, Ludo Lavreys +24 more

Perspectives on Using Race in Pulmonary Function Testing: A National Survey of Fellows and Program Directors

Respiratory Care(2024)10.4187/respcare.11734

N/A

0DataRank · unranked

5 citations

Sara Aijaz, Nicholas J. Nassikas, Parvati Singh, S. Lakshman, Chelsea Boyd +11 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

UNC Libraries(2024)10.17615/jk04-ea73

N/A

0DataRank · unranked

0 citations

Carlos del Rı́o, Adrian B. McDermott, Estelle Piwowar‐Manning, Timothy Skalland, Margaret E. Ackerman +29 more

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial

medRxiv(2025)10.1101/2025.09.12.25335655

N/A

0DataRank · unranked

0 citations

Stephen R. Walsh, Masataka Suzuki, Michaël Desjardins, Alisse Hannaford, Amy C Sherman +17 more